#1. SOLÉ, Dirceu; KUSCHNIR, Fábio Chigres; PASTORINO, Antônio Carlos; et al. V Brazilian Consensus on Rhinitis – 2024. Brazilian Journal of Otorhinolaryngology, 2024.
#2. XU, F.; YANG, K. Examining the correlation between allergic conjunctivitis and allergic rhinitis. Alternative Therapies in Health and Medicine, v. 30, n. 2, p. 106-110, 2024.
#3. DIMOU, M. V.; XEPAPADAKI, P.; LAKOUMENTAS, J.; et al. Levels of IgE sensitization drive symptom thresholds in allergic rhinitis. Annals of Allergy, Asthma & Immunology, v. 133, n. 2, p. 177-185.e10, 2024.
#4. WANG, Y.; LI, X.; GU, S.; FU, J. Characterization of dysbiosis of the conjunctival microbiome and nasal microbiome associated with allergic rhinoconjunctivitis and allergic rhinitis. Frontiers in Immunology, v. 14, p. 1079154, 2023.
#5. MENDELSON, S.; QUINTANILLA, J.; NORRIS, M. R.; BIELORY, L. Psychosocial impact of ocular surface allergic inflammatory disorders. Current Opinion in Allergy and Clinical Immunology, v. 21, n. 5, p. 465-471, 2021.
#6. LEONARDI, A.; SILVA, D.; PEREZ FORMIGO, D.; et al. Management of ocular allergy. Allergy, v. 74, n. 9, p. 1611-1630, 2019.
#7. WALLACE, D. V.; DYKIEWICZ, M. S.; BERNSTEIN, D. I.; et al. The diagnosis and management of rhinitis: An updated practice parameter. Journal of Allergy and Clinical Immunology, v. 122, n. 2, p. S1-S84, 2008.
#8. DALEY-YATES, P.; LARENAS-LINNEMANN, D., BHARGAVE, C.; et al. Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index. J Asthma Allergy, v. 14, p. 1093-1104, 2021.
#9. ANEEZA, W. H. et al. Efficacy of Mometasone Furoate and Fluticasone Furoate on Persistent Allergic Rhinoconjunctivitis. Allergy & Rhinology, v. 4, n. 3, 2013.
#10. Bula do medicamento. Disponível em: <https://br.gsk.com/media/6298/avamys.pdf>.
#11. BERGER, W.; GODFREY, J.; SLATER, A. Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance. Expert Opin Drug Deliv, v. 4, n. 6, p. 689- 701, 2007.
#12. MELTZER, E.; STAHLMAN, J.; LEFLEIN, J.; et al. Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: a randomized, multicenter, double-blind, single-dose, crossover study. Clin Ther, v. 30, n. 2, p. 271-279, 2008.
#13. BAUMANN, D.; BACHERT, C.; HOGGER, P. Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo. Clin Exp Allergy, v. 39, n. 10, p. 1540-1550, 2009.
#14. DE LOTT, L. B.; KHAN, N.; WOODWARD, M. A.; CLAUW, D. J.; GALOR, A. Antidepressant medication used for treatment of chronic ocular pain. Cornea, v. 43, n. 11, p. 1335-1339, 2024.
Exclusividade médica
